ࡱ > g s bjbjVV #z r< r< ) 5 T T 8 4 H h \ \ r r r Z \ \ \ \ \ \ $ C 6 " T T r r | T " r r Z Z v r r @t " p F 0 + + + , + : Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry a prospectively controlled randomized double-blind clinical trial Martin Beiderlinden, Patrick Werner, Astrid Bahlmann, Johann Kemper, Tobias Brezina, Maximilian Schfer, Klaus Grlinger, Holger Seidel, Peter Kienbaum and Tanja A Treschan Additional file 1. Correlation between PT (Quick) and argatroban and lepirudin plasma levels X-axis depicts plasma concentration in g/ml, Y-axis displays Quick in seconds. Each dot represents one pair of measurements. a) Argatroban, b) Lepirudin. Spearman correlation coefficient (r) and level of significance are presented in each panel, p<0.01 was considered statistically significant. PAGE \* MERGEFORMAT1 a) r=-0.23; p=0.1 b) r=0.05, p=0.97 ' Q | ( 9 h j k n ŴssbZVZVZVZV h. j h. U!j hXu hXu OJ QJ U^J h8%C hy? OJ QJ ^J h hy? OJ QJ ^J hy? OJ QJ ^J hy? 5OJ QJ ^J #hy? hy? 5OJ QJ ^J mHsH hy? hy? OJ QJ ^J mHsH h hy? OJ QJ ^J h^zY hy? 5CJ OJ QJ ^J h hy? 5CJ OJ QJ ^J hy? 5CJ OJ QJ ^J : ; < = @ A P Q 9D [$ \$ gdXu $a$ d $d a$gdy? $d a$gdy? ! 6 7 8 9 < = ? A O Q R S T U V W X Y [ ] k m n o p q r s ǰǪǪǪǪǏǪǪ h hy? OJ QJ ^J 5hXu hXu B*CJ KH OJ QJ ^J aJ mHph sH hXu PJ -hXu hXu B*CJ KH OJ QJ ^J aJ ph hXu 5hXu hXu B*CJ KH OJ QJ ^J aJ mHph sHh. hXu mH nH uh j h U Q R S T U V W X Y \ ] l m n o p q r s $d a$gdy? 9D [$ \$ gdXu gdXu 6 P 1h:p |. A!"#$n% n3 *_' gyPNG IHDR u S 3fIDATxHwqxLwLlÖ!2D,kC,ujne'zx7"=x"j%˅Rȕ%H~_s|F?F̏ϧK n + + uw{ p? ,r_: 瞣 W @_+ +} W } J_ @_+ W } W @_+ <{***oN>]XXWVV4G_=W }}]SNu8q&&&&N